Clinical Trials, Treatment and Workshop

Clinical Trials

Treatment

Workshop

TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

Treatment

Treatment Conditions Medicine Clinical Trials

What’s Next for the NIH When it Comes to Psychedelics?

Veriheal

JUNE 24, 2021

Perhaps this resurgence of interest in psychedelics for medicinal purposes has been enough to redirect the NIH away from focusing on posing psychedelics as drugs of abuse and towards investigating the substances as a treatment option for those who have none or have been receiving ineffective treatments. .

Research and Development

Research and Development Clinical Trials Treatment Access

Join 14,000+

Insiders

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Silo Wellness And Kaivalya Kollectiv Announce Psychedelic Retreats

SpeedWeed

MAY 12, 2021

Under the newly announced partnership, Silo Wellness will operate two 5-MeO-DMT retreats in Jamaica, where the company already conducts psilocybin-assisted retreats and mushroom and truffle cultivation workshops. .

Clinical Trials

Clinical Trials Therapy Cultivation Events

Breaking the Stigma: Shifting Attitudes Toward Medical Marijuana Nationwide

MMJ Recs

DECEMBER 22, 2023

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. These campaigns focus on dispelling myths, highlighting success stories, and educating the public about the science behind cannabis-based treatments.

Marijuana

Marijuana Chronic Pain Advocacy Research and Development

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/rosalind-watts-89527660/.